Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancer

19 Nov 2023

Abstract excerpt

OBJECTIVE: The solute carrier family 25 member 1 (SLC25A1) is currently the only known human transporter for citrate in the mitochondrial membrane. However, its role in cancer development remains to be elucidated. We aim to analyze the expression profile, prognostic value, potential immunological significance, and effect on tumor growth of SLC25A1 at a pan-cancer level. METHODS: Herein, the role of SLC25A1 in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Mitochondrial Function and Pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37981593
DOI: 10.1007/s12672-023-00830-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancerPMID 37981593Read ↗

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancerSemantic proximity Read ↗

Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) in Pan-CancerSemantic proximity Read ↗

A pan-cancer analysis of SLC1A5 in human cancersSemantic proximity Read ↗

An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesisSemantic proximity Read ↗

Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan‐CancerSemantic proximity Read ↗

Comprehensive bioinformatics analysis of the solute carrier family and preliminary exploration of SLC25A29 in lung adenocarcinomaSemantic proximity Read ↗

Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor typesSemantic proximity Read ↗

Comprehensive molecular and clinical characterization of SLC1A5 in human cancersSemantic proximity Read ↗

Systematic Pan-Cancer Analysis Identifies SLC31A1 as a Biomarker in Multiple Tumor TypesSemantic proximity Read ↗

Comprehensive Pan-cancer Analysis of Cuproptosis-related Gene SLC31A1 as a Potential Biomarker for Cancer Survival and ImmunotherapySemantic proximity Read ↗

SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysisSemantic proximity Read ↗

Comprehensive analysis of mitochondrial solute carrier family 25 (SLC25) identifies member 19 (SLC25A19) as a regulatory factor in hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.